Member Info for mulledwine

Eckoh announces major three-year contract renewal with Vue Cinemas Eckoh plc (AIM: ECK), the UK's leading provider of speech recognition and associated payment solutions, today announced that it has successfully renewed its contract to provide speech recognition telephony services and a live contact centre to Vue Entertainment Ltd, the UK's leading developer and operator of state-of-the-art cinemas. Vue has consistently been one of Eckoh's most significant accounts and is the largest revenue client to come up for renewal this financial year. Through the contract, Eckoh will supply a customer service solution that includes a speech-enabled cinema information and ticket booking service; and a live UK-based contact centre that will manage customer calls and emails as well as Vue's gift card operations. The three year contract, which runs until October 2015, has also made provision to include social media monitoring and broader customer interaction that will utilise further Eckoh's multi-channel service capability. The market leading speech recognition solution is hosted on Eckoh's VoiceXML processing platform and receives over a million calls every year from Vue's customers.

http://www.investegate.co.uk/Article.aspx?id=201210110700034228O

Tony Shearer, Chairman, said “I am very pleased to welcome Eric to our board. In getting to know each other, he has already made a very strong impression. Eric has significant experience in mining globally and, in particular in South America, and his experience will prove invaluable to the Board of Orosur.”

Orosur Mining Inc. Announces Appointment of Non... Orosur Mining Inc. Announces Appointment of Non Executive Director Orosur Mining Inc Orosur Mining Inc. (“Orosur” or the "Company") (TSX: OMI) (LSE: OMI) announced today the appointment of Dr. Eric Roth as Non Executive Director of the Company. Eric is 46 years old and is based in Santiago, Chile. He is Doctor of Philosophy (Ph.D.) in Economic Geology and is a Fellow of the AusIMM. Dr Roth was President, CEO and Director at Extorre Gold Mines Ltd prior to their acquisition by Yamana Gold Inc. for US$403.6 million in August 2012. Before this, he performed advisory services for various clients including Exeter Resource Corp., Kinross Gold and AngloGold Ashanti Ltd and has worked as Exploration Manager for Aur Resources Inc. Dr Roth also served as Global Head of Greenfields Exploration for AngloGold Ashanti Ltd. where he was responsible for their technical management of, and the provision of strategic direction for their greenfields exploration program.

http://www.investegate.co.uk/Article.aspx?id=20121011070000Z7387

MINING AND PROCESSING OPERATIONS During the quarter ended 30 September 2012, open pit mining operations extracted 185,300 tonnes of ore averaging 1.2g/t Au. The metallurgical plant processed 167,242 tonnes of open pit and underground material and produced a total of 5,875 ounces of gold and 7,469 ounces of silver; with plant recovery averaging 80.8%. Plant throughput was constrained by reduced tailings dam capacity which will improve in Q4 with the reinstatement of Tailings Dam No. 3. UNDERGROUND Trial mining from the underground delivered 15,125 tonnes of ore averaging 3.32g/t Au. Some of this ore has already been processed and the remainder will be processed in Q4. During the past quarter a strategic review of the underground operations was completed which led to a decision to temporarily suspend underground operations. The contractor is currently completing mining of accessible ore zones and will demobilise from site in late October 2012 at which point capital expenditure on the underground mine will temporarily cease. UNDERGROUND DRILLING As part of the strategic review of the underground operation, Hambledon’s 25,000m diamond drill programme will continue. To date, some 17,500 metres has been drilled. The next set of drill results will be announced shortly. INFRASTRUCTURE The repair to Tailings Dam No. 3 is complete. The dam is expected to be commissioned in November 2012 after receipt of government permits.

http://www.investegate.co.uk/Article.aspx?id=20121011070000Z7379

WANdisco* (WAND) announced that third quarter, ended 30th September, subscription bookings rose to 2.0 million dollars (1.3 million pounds), up 86% from 2011's comparable period, bringing total bookings for the year-to-date to 5.4 million dollars (3.4 million pounds). The software developer noted that it secured a number of new blue-chip clients, including Nokia Siemens Networks and Home Depot while also achieving an annualised renewal rate of 117%. The shares jumped by 34p to 435p.

Shore Capital reiterated its "buy" recommendation for Bunzl (BNZL) ahead of the haulage company issuing its third quarter results. The broker expects the firm to report organic revenue growth of between 4% and 5%, driven by its North American operations. Shore added that the company's margins are likely to improve by around 10 basis points as its sales mix in the UK and North America improves. The broker noted that the group is still facing headwinds in the UK but believes that conditions will improve in the 2013 financial year. The shares dropped by 15p to 1,101p.

N+1 Singer upgraded its rating for Mythrah Energy (MYT) from "hold" to "buy" with an increased target price of 73.7p, from 58p. The India focused wind farm operator's shares have fallen by 50% since March, which the broker attributed to delays in the commissioning of its development portfolio. Singer said that when operational this will add 270 megawatts to its existing capacity of 340 megawatts. On the broker's forecasts, the shares trade on a prospective earnings multiple of 17.9 times for 2013, falling to 6.5 times in 2014. Mythrah shares slipped by 0.75p to 61p.

Coverage of the same Panmure Gordon retained its "sell" stance for Home Retail Group (HOME) with a 51p target price. The broker expects the company's first half pre-tax profits to have halved to 14 million pounds and believes that the Argos operator will struggle during the Christmas trading period, due to high levels of pricing competition from company's such as Amazon and John Lewis. Panmure forecasts Argos to be loss making in the 2014 financial year, claiming that it has too many stores and that a large scale closure programme is required. The shares rose by 2.9p to 100.2p.

Valuation: Look for growth in portfolio value We contend the basis for investment in Imperial Innovations is the expectation of future portfolio value appreciation and realisations. This should arise from successful IP commercialisation by portfolio companies and be crystallised by liquidity events. Imperial Innovations has historically been able to grow the value of its portfolio over and above the net new investment and has also traded at a premium to NAV, which can be ascribed in part to hidden (unrealised) value in portfolio companies.

http://www.edisoninvestmentresearch.co.uk/researchreports/IVO_Update_101012.pdf

Valuation: Waiting for bookings upturn XP trades on a P/E multiple of 11.8x FY12e and 10.4x FY13e revised EPS, with a forecast dividend yield of 4.8%. It trades in line with UK distributors and towards the lower end of global power converter companies, a discount not justified by its superior margins or dividend yield support, in our view. To see upside from this point, investors will need to see evidence of a sustained improvement in bookings in Q4 and into 2013.

http://www.edisoninvestmentresearch.co.uk/researchreports/XPPower091012update.pdf

Valuation: Discounting the growth opportunity The high P/E reflects our assumption that Endace will continue investing heavily in growth, but if current gross margins and cost control trends continue, our 2014 could be a multiple of the current forecast. The EV/Sales ratios of 1.5x and 1.3x for 2013 and 2014 look very conservative given the growth opportunity.

http://www.edisoninvestmentresearch.co.uk/researchreports/Endace091012update.pdf

Valuation: Risk-adjusted NPV of £416m (125p/share) We maintain our £416m Vectura valuation, but expect to increase this after Europe and Japan launch timings for Seebri are clarified, and on EU filing of QVA149 (expected by the year end). Upside could come from regulatory and clinical progress, more regulatory clarity or further technology licences

http://www.edisoninvestmentresearch.co.uk/researchreports/Vectura091012update.pdf

sorry wrong board !